NeuroPace
$16.96
5
-$0.84-4.72% 14:04 Today
Statistics
Day High
17.99
Day Low
16.93
52W High
19.6
52W Low
7.56
Volume
17,804
Avg. Volume
-
Mkt Cap
578.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6AugExpected
Expected EPS
-0.217496
Actual EPS
N/A
Financials
-21.47%Profit Margin
Unprofitable99.99MRevenue
-21.47MNet Income
Analyst Ratings
20.00Average Price Target
The highest estimate is 20.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NPCE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap106.49B
Abbott Laboratories
ABT
Mkt Cap166.17B
LivaNova
LIVN
Mkt Cap4.59B
Smith & Nephew
SNN
Mkt Cap12.78B
Boston Scientific
BSX
Mkt Cap67.09B
Novartis
NVS
Mkt Cap305.1B
Pfizer
PFE
Mkt Cap138.61B
Johnson & Johnson
JNJ
Mkt Cap633.19B
Zoetis
ZTS
Mkt Cap31.36B
About
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Show more...
CEO
Mr. Joel D. Becker
Employees
203
Country
United States
ISIN
US6412881053
Listings
0 Comments
Share your thoughts
FAQ
What is NeuroPace stock price today?▼
The current price of NPCE is $16.96 USD — it has decreased by -4.72% in the past 24 hours. Watch NeuroPace stock price performance more closely on the chart.
What is NeuroPace stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange NeuroPace stocks are traded under the ticker NPCE.
Is NeuroPace stock price growing?▼
NPCE stock has risen by +8.24% compared to the previous week, the month change is a +9.21% rise, over the last year NeuroPace has showed a +64.77% increase.
What is NeuroPace market cap?▼
Today NeuroPace has the market capitalization of 578.23M
When is the next NeuroPace earnings date?▼
NeuroPace is going to release the next earnings report on August 06, 2026.
What were NeuroPace earnings last quarter?▼
NPCE earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.23 USD resulting in a +42.58% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NeuroPace revenue for the last year?▼
NeuroPace revenue for the last year amounts to 99.99M USD.
What is NeuroPace net income for the last year?▼
NPCE net income for the last year is -21.47M USD.
How many employees does NeuroPace have?▼
As of July 08, 2026, the company has 203 employees.
In which sector is NeuroPace located?▼
NeuroPace operates in the Health & Wellness sector.
When did NeuroPace complete a stock split?▼
NeuroPace has not had any recent stock splits.
Where is NeuroPace headquartered?▼
NeuroPace is headquartered in Mountain View, United States.